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Abstract
Objective—Cancer-related fatigue (CRF) is one of the most common, persistent, and disabling 
symptoms associated with cancer and its treatment. Evidence-based treatments that are acceptable 
to patients are critically needed. This study examined the efficacy of Mindfulness-Based Stress 
Reduction (MBSR) for CRF and related symptoms.
Method—A sample of 35 cancer survivors with clinically-significant CRF was randomly 
assigned to a 7-week MBSR-based intervention or wait-list control group. The intervention group 
received training in mindfulness meditation, yoga, and self-regulatory responses to stress. Fatigue 
interference (primary outcome) and a variety of secondary outcomes (e.g., fatigue severity, 
vitality, disability, depression, anxiety, sleep disturbance) were assessed at baseline, post-
intervention, and 1-month follow-up. Bonferroni correction was employed to account for multiple 
comparisons. Controls received the intervention after the 1-month follow-up. Participants in both 
groups were followed for 6 months after completing their respective MBSR courses to assess 
maintenance of effects.
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Results—Compared to controls, the MBSR group reported large post-intervention reductions as 
assessed by effect sizes (d) in the primary outcome, fatigue interference (d= −1.43, p<.001), along 
with fatigue severity (d= −1.55, p<.001), vitality (d= 1.29, p<.001), depression (d= −1.30, p<.001), 
and sleep disturbance (d= −0.74, p=.001). Results were maintained or strengthened at 1-month 
follow-up, the point at which significant improvements in disability (d= −1.22, p<.002) and 
anxiety (d= −0.98, p=.002) occurred. Improvements in all outcomes were maintained 6 months 
after completing the course. MBSR adherence was high, with 90% attendance across groups and 
high rates of participant-reported home practice of mindfulness.
Conclusions—MBSR is a promising treatment for CRF and associated symptoms.
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Fatigue is a highly prevalent and bothersome symptom for patients with cancer [1, 2]. 
Survivors have identified it as the most distressing [3] and debilitating [4] of all their 
symptoms in research; yet it is under-reported in the clinic and is seldom diagnosed or 
treated. Across studies, fatigue prevalence rates range from 59 to 100% [5, 6], and from 9 to 
56% when syndromal diagnostic criteria for cancer-related fatigue (CRF) are applied [7]. 
CRF causes interference in quality of life across the cancer trajectory that has been 
characterized as profound and pervasive [4], sometimes persisting long after treatment has 
ended even in patients believed to be disease-free [5].
While research related to CRF has intensified recently [5], no “gold standard” treatment for 
it exists [8]. National Comprehensive Cancer Network (NCCN) treatment guidelines suggest 
that in response to a complaint of fatigue, providers should direct attention to potential 
contributing factors that may be correctable, such as anemia and pain [2]. For many patients, 
however, no specific treatable cause will be known. Pharmacologic interventions such as 
psychostimulants are considered “investigational” and secondary to nonpharmacologic 
interventions in the NCCN guidelines. A recent meta-analysis suggested that exercise-based 
treatments are helpful in addressing CRF [9]. In a comprehensive meta-analysis of 57 non-
pharmacological interventions for cancer patients and survivors, Kangas and colleagues [8] 
concluded that exercise and psychosocial therapies each show potential for effectively 
ameliorating CRF.
Extant evidence suggests that integrative therapeutic approaches combining exercise and 
psychosocial interventions may best serve those suffering with CRF [2, 8, 10]. Mindfulness-
Based Stress Reduction (MBSR) is an integrative intervention that has been identified as 
promising for CRF and worthy of further study [10, 11]. Within a group framework of 
experiential and didactic learning that includes meditation and yoga, participants cultivate 
the innate human quality of mindfulness [12]. Mindfulness has been defined as intentionally 
directing attention to one's present moment experience without judging that experience as 
positive or negative [13]. MBSR participants learn less reactive, healthier responses to 
stressful situations. The gentle hatha yoga included in MBSR as a practice of mindfulness in 
movement may serve to counteract deconditioning due to physical inactivity that is common 
among those with CRF.
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Several meta-analyses and systematic reviews have suggested MBSR has promise in the 
cancer context [14-17]. Three randomized controlled trials (RCTs) of MBSR for cancer 
patients have included measures of fatigue, vigor, or vitality among the outcomes in their 
trials and found positive effects [18-20]. Fatigue was not the primary outcome in these trials, 
however, and none enrolled participants based on the presence of clinically significant 
fatigue. Only one study tested a mindfulness-based intervention specifically targeting fatigue 
in cancer survivors [21]. Investigators compared modified Mindfulness-Based Cognitive 
Therapy to a wait-list control and found the intervention group had significantly lower 
fatigue scores at the end of the 8-week class compared to controls.
The current pilot study targeted cancer-related fatigue interference as the primary outcome 
and included a wait-list control group for comparison at post-intervention and 1-month 
follow-up. We hypothesized that mindfulness training would reduce patients’ perception of 
the interference of fatigue and that improvements would be sustained through 1-month 
follow-up. Similarly, we hypothesized that mindfulness training would reduce fatigue 
severity, functional disability, depression, anxiety, and sleep disturbance, while improving 
vitality. We followed both groups to six months after participating in MBSR.
Methods
Design
A randomized controlled design was used to enroll a heterogeneous sample of 35 cancer 
survivors in a 1:1 ratio to either a 7-week MBSR course or a wait-list control condition. A 
wait-list control was utilized since MBSR had not been established as an effective 
intervention for CRF when the study began, and we wanted to see if there was a significant 
effect before comparing to attention control or an active comparator. Participants completed 
self-report measures at baseline (T1) and then were randomized. Subsequent assessments 
were completed at the end of the intervention (T2) and at 1-month follow-up (T3), which 
served as the end of the randomized portion of the trial. The wait-list participants were 
offered the 7-week MBSR course following completion of the T3 assessment, and all 
elected to participate. Wait-list participants completed the self-report measures immediately 
after the MBSR course (T4). Both groups completed a final assessment 6 months after 
completing their respective MBSR courses (T5). The study was approved by the Indiana 
University institutional review board (IRB) and is registered with ClinicalTrials.gov 
(NCT01247532).
Participants
Individuals were considered eligible if they were at least 18, had a cancer diagnosis, 
reported experiencing persistent CRF for the previous 8 weeks or longer, and reported 
clinically significant CRF at the time of eligibility screening. Clinically significant CRF was 
defined by a cutoff mean score of ≥ 4 across the 3-item Fatigue Symptom Inventory severity 
composite [FSI composite; 22]. Participants were excluded if they had cancer treatment 
(other than endocrine therapy for breast cancer) in the prior 3 months, were enrolled in 
hospice care, had severe hearing impairment, were experiencing severe depression (PHQ-8 
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≥ 20), had previously participated in a mindfulness meditation class, or did not understand 
English. Figure 1 represents the participant flow of the study.
Baseline characteristics are presented by intervention arm in Table 1. Breast cancer was the 
most frequent diagnosis (85.7%), and the sample was predominantly female (94%), white 
(80%), and college educated (71%). About half were employed (49%), 60% were married, 
and 60% reported having a comfortable income. All had completed chemotherapy and/or 
radiation therapy at least 9 months before randomization, and the average time since 
completion was 51.3 months (SD = 39.3 months). Most (94.3%) were in an early stage of 
disease (stage 0 to III) at diagnosis.
Procedures
The sample of 35 participants in this trial was recruited over 6 weeks in the spring of 2010. 
Participants were consecutively recruited through: (1) clinics affiliated with a National 
Cancer Institute-designated cancer center, (2) an urban oncology clinic affiliated with a 
public teaching hospital in the Midwest, and (3) a breast cancer survivor registry. Eligible 
and interested individuals were invited to attend one of two group enrollment sessions. The 
enrollment sessions included informed consent, baseline assessment, randomization, and—
for those randomized to the intervention arm—orientation to the MBSR class. The 
randomization sequence was generated by coin toss in blocks of four by the principal 
investigator. Research assistants and participants were blinded to the randomization 
sequence using sequentially-numbered and sealed envelopes. All outcomes were self-
reported on study questionnaires and therefore not subject to bias by assessor interpretation. 
Participants completed baseline and post-intervention questionnaires at the study site, and 
follow-up assessments were completed either at the study site or by mail according to 
participant preference. The 6-month follow-up assessments were completed in early 2011.
Intervention
The MBSR-CRF program tested in this study maintained fidelity to standard MBSR [13]. It 
featured training in the mindfulness practices of the body scan, sitting meditation, gentle 
hatha yoga, walking meditation, and compassion meditation. The protocol was adapted for 
the cancer context, a practice which has precedent in previous studies [23]. MBSR-CRF 
adaptations included 2-hour classes, seven classes instead of eight, no retreat, brief psycho-
education related to CRF, and shorter guided home practices (20 minutes) to accommodate 
fatigued participants; however, all of the core content of the standard MBSR curriculum was 
included. Recordings of guided meditations of body scan, sitting meditation, gentle hatha 
yoga with chair adaptations, and compassion meditation were created by the facilitator for 
home practice.
For participants whose cancer diagnosis and treatment stimulated reactivity in attention to 
particular body areas (e.g., during the body scan), guidance was to acknowledge associated 
thoughts, emotions, and sensations in non-judgmental compassion, while offering the 
possibility of grounding in sensations of lesser valence such as those of the breath or contact 
with body support (e.g., chair, floor). Class discussion included the contrast between 
catastrophizing and being willing to connect with present moment experience of transient 
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thoughts, emotions, and sensations. Given the high rates of sleep disturbance in the sample, 
an optional 8-minute bedtime body scan variant, “Arriving for Sleep,” was provided to 
lessen pre-sleep rumination and difficulties initiating sleep.
Information on the human stress reaction routinely presented in MBSR was expanded to 
include evidence of the relationship of stress and fatigue [24]. Information regarding the 
influence of the perception of exhaustion on subsequent diminished physical activity [25] as 
well as ample evidence that physical activity is helpful with CRF [9] were included. Mindful 
communication practice based in insight dialogue [26] was used as a vehicle for participants 
to explore how newly-developing strategies learned in mindfulness meet the interpersonal 
challenges of CRF.
Participants logged their daily home meditation practice, including number of minutes per 
day and type of practice (i.e., body scan, sitting meditation, yoga) on a diary card. 
Participants received $5 for each weekly diary card submitted, regardless of the logged 
amount of home practice. The course instructor was blinded to patient logs and outcomes 
during the class. The instructor had six years of MBSR teaching experience, completing all 
components of professional training leading to eligibility for MBSR Teacher Certification 
Review (Phase 4, Oasis Institute at the Center for Mindfulness in Medicine, Health Care and 
Society; [13].
Measures
Fatigue—The interference subscale of the Fatigue Symptom Inventory (FSI) was the 
primary outcome measure. The FSI is a 13-item self-report scale assessing the degree to 
which fatigue interferes with quality of life (7 items) as well as the severity (4 items) and 
frequency (2 items) of fatigue [27]. Interference is measured on 11-point scales that assess 
the degree fatigue interfered with general level of activity, ability to bathe and dress, normal 
work activity, ability to concentrate, relations with others, enjoyment of life, and mood. FSI 
severity is measured on 11-point scales that assess most, least, and average fatigue in the 
past week as well as current fatigue. FSI frequency is measured with two items assessing the 
number of days and the percentage of the average day over the past week the respondent felt 
fatigued.
The 4-item vitality scale of the SF-36 Health Survey served as a secondary fatigue measure 
[28]. Standardized subscale scores range from 0 to 100, with higher scores indicating greater 
vitality. Vitality scores ≤ 45 are indicative of clinically-significant CRF [22].
Secondary Outcomes—Functional status was assessed with the 3-item Sheehan 
Disability Scale [SDS; 29] which asks respondents to what extent on a 0 to 10 scale their 
health has interfered with their work, family life, and social life in the previous week. The 
SDS score is the mean of the three items and higher scores reflect greater disability. 
Depression severity was measured with the Patient Health Questionnaire 8-item depression 
scale (PHQ-8). PHQ-8 scores range from 0 to 24, with scores of 5, 10, 15, and 20 
representing mild, moderate, moderately severe, and severe depression, respectively [30]. 
Anxiety was measured with the 7-item Patient Health Questionnaire Generalized Anxiety 
Disorder Scale (GAD-7) [31]. Scores range from 0 to 21, with cut-points of 5, 10, and 15 
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representing mild, moderate, and severe levels of anxiety. Sleep disturbance was measured 
with the 7-item Insomnia Severity Index [ISI; 32], which evaluates the perceived severity of 
insomnia and the impact of sleep difficulties over the course of the previous two weeks. The 
ISI has been found to be a reliable and valid instrument to assess primary insomnia [33], as 
well as insomnia secondary to cancer [34].
Feasibility and Adherence. Retention through the 6-month follow-up period was chosen as 
the main feasibility measure. To measure adherence to the MBSR program, class attendance 
was tracked, along with number of home practice logs submitted, and the total number of 
days and minutes per day of mindfulness practice reported. At the end of the course, 
participants were asked to report the average number of days per week they had continued to 
participate in formal and informal mindfulness practice.
Analysis
The randomized groups were compared on T1 characteristics (e.g., demographic 
characteristics, medical comorbidity, recent mental health treatment, and self-reported 
mindfulness) to determine whether to adjust for any of these variables in subsequent 
analyses due to potentially confounding effects on outcomes. The only significant T1 
differences between groups were in recent participation in mental health treatment (p = . 02) 
and degree of mindfulness on two subscales of the Five Facet Mindfulness Questionnaire 
[Observing, p=.04; Non-Reactivity, p=.02; 35]. These differences were controlled in 
subsequent analyses.
An ANCOVA model was used to test efficacy by comparing the MBSR and control groups 
on all outcomes immediately after the intervention (T2) and 1 month later (T3), while 
adjusting for baseline scale scores for each variable. A Bonferroni correction was used to 
maintain the family-wise Type I error rate <0.05 across the 18 comparisons in the 
randomized portion of the trial (9 comparisons each at T2 and T3; see Table 2). Thus a 
conservative two-tailed p-value of <0.00278 (=0.05/18) was considered statistically 
significant. Effect sizes for each outcome variable were calculated as the standardized mean 
difference between the MBSR and wait-list control groups at T2 and T3 in fatigue and other 
outcomes, divided by the pooled baseline standard deviation of the particular outcome 
variable.
Paired t-tests were used to assess for within-group improvement on all outcomes for each 
group after completing the MBSR course, as well as to assess for maintenance of 
intervention benefits from immediate post-intervention to 6 months post-intervention. 
Analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, North Carolina).
Results
Randomized Controlled Trial to Test Efficacy of MBSR
Primary outcome—As shown in Table 2, the MBSR group demonstrated significantly 
greater improvement than the control group in fatigue interference as measured against the 
Bonferroni-corrected significance level of p < .00278 at T2 and T3. Effect sizes (d) for 
group differences (adjusted for baseline levels) in fatigue interference were large at both 
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time points, ranging from −1.43 at T2 to −1.34 at T3. The post-intervention effect on fatigue 
interference for each group can be observed visually in Figure 2a.
Secondary outcomes—The MBSR group demonstrated significantly greater 
improvement than the control group on all secondary fatigue measures (i.e., fatigue severity, 
fatigue days, and percent of day fatigued) and vitality at T2 and T3, as shown in Table 2. 
Effect sizes on all outcomes were large, ranging from −1.08 to −1.83 for T2 measures and 
from −1.22 to −1.73 for T3 measures. Functional disability scores were lower in the MBSR 
group at T2 (d = −0.45), although not statistically different (p = 0.25); however, at T3 the 
MBSR group demonstrated significantly lower functional disability scores than controls (p 
= .0013) with a large effect size (d = −1.22).
Depression scores were significantly lower (p < .001) for MBSR than controls with large 
differences at T2 (d = −1.30) and T3 (d = −1.71). Sleep disturbance was significantly 
improved for MBSR compared to the control condition at both T2 (d = −0.74) and T3 (d = 
−1.00). Anxiety scores were lower in the intervention group at T2 than for the control group 
(d = −0.47), although not statistically different (p = 0.10). By T3, however, the MBSR group 
demonstrated significantly lower anxiety scores than the control group (p = 0.002) with a 
large effect size (d = −0.98).
Analysis of Wait-List Controls
The wait-list control group received the MBSR intervention immediately after their T3 
assessment and was assessed again immediately after, and 6 months after, completion of the 
intervention. The post-intervention effect on fatigue interference for each group after 
completing MBSR can be observed visually in Figure 2b. Both groups experienced 
significant within-group improvements in all outcomes after completing the MBSR course.
Maintenance of Post-Intervention Effects in Both Groups
Improvements after MBSR in all outcomes were sustained or strengthened at the 6-month 
follow-up in each group. Paired t-tests demonstrated that none of the outcomes changed 
significantly for either group between their post-MBSR assessment and the 6-month follow-
up. In fact, Figure 2b shows that 6 months after completing the MBSR course, both groups 
had improved similar amounts from their baseline fatigue interference score.
Feasibility and Adherence
All participants (N=35) completed the study through T3, with one member of the control 
group dropping out at the 6-month follow-up. Attendance rates were 88% in the intervention 
group and 91% when the control group received the MBSR course. No adverse events were 
reported, and the intervention was well-tolerated by all participants. As for home practice 
participation, 16 of 18 participants randomized to MBSR turned in practice logs each week 
and reported practicing the body scan, yoga, or sitting meditation an average of 28 out of 36 
recommended days of home practice during the program. Average number of minutes of 
practice daily was 35 (SD = 15). Number of practice logs submitted and practice time was 
similar for the wait-list group when they participated in MBSR. Among the 34 who 
completed the 6-month follow-up, 74% reported continued “formal” mindfulness practice 
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and 88% reported continued “informal” mindfulness practice since the completion of the 
MBSR course. Participants reported engaging in “formal” mindfulness practices (e.g., body 
scan, sitting meditation) 2 days per week for 20 minutes per day on average over the 
preceding 6 months. Participants reported “informal” mindfulness practice (e.g., doing 
everyday activities mindfully) 3.8 days per week on average.
Discussion
This study has four important findings. First, MBSR participants demonstrated significantly 
greater improvements in fatigue interference than wait-list controls, which supported the 
primary hypothesis. The magnitude of the effect of MBSR on this and other fatigue 
outcomes including fatigue severity and vitality was large at the end of the intervention and 
one month later. Second, MBSR resulted in significant and sustained improvements in 
depression and sleep disturbance at both time points, with significant improvements in 
anxiety and functional disability emerging at 1 month. In total, 16 of 18 comparisons on 
primary and secondary outcomes across T2 and T3 were statistically significant after 
adjusting for multiple comparisons. Third, improvements in all symptoms were maintained 
for at least 6 months beyond the completion of the MBSR course for both groups after their 
respective courses. Fourth, MBSR proved acceptable to fatigued cancer survivors, evidenced 
by high rates of attendance and mindfulness practice during the course and moderate 
amounts of continued mindfulness practice, particularly informal practice, through the 6-
month follow-up period.
The current findings are generally consistent with the four published RCTs of mindfulness-
based interventions in cancer that included fatigue, vigor, or vitality among the outcome 
measures [18-21]. Although only one of these trials [21] was testing an intervention to help 
with CRF specifically, each found evidence to suggest fatigue, vigor, and/or vitality 
improved after a mindfulness course. The only null finding for a fatigue outcome across 
these four trials was reported by Speca and colleagues (2000). In their trial of a 10.5-hour 
adaptation of MBSR, the change in fatigue was non-significant, which is not surprising since 
participants were not enrolled based on a fatigue eligibility criterion; however, vigor 
improved significantly.
The previous study most analogous to the present trial is that of van der Lee and Garssen 
[21]. Both trials included a heterogeneous sample of post-treatment cancer survivors 
enrolled based on the presence of clinically significant fatigue and randomized to either a 
mindfulness-based intervention for CRF or a wait-list control group. van der Lee and 
Garssen tested an adaptation of Mindfulness-Based Cognitive Therapy (MBCT) for 59 
adults with CRF compared to 24 assigned to the wait list. MBCT and MBSR are similar 
courses, with a principal difference being that MBCT includes cognitive therapy 
components which are not part of MBSR, and which are particularly relevant for people 
vulnerable to depression. The MBCT intervention included 26 hours of class time plus a 2.5-
hour booster compared to our 15-hour MBSR course with no booster. Another difference is 
that van der Lee and Garssen invited their wait-list controls to participate in the MBCT 
program immediately after the post-intervention assessment, whereas randomization was 
maintained in the current trial through the 1-month follow-up. Participants in the MBCT 
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trial had significantly reduced post-intervention fatigue compared to controls, with a rather 
large effect size favoring MBCT (d = 0.74). In the present study, MBSR produced similar 
but larger effect sizes on fatigue interference, fatigue severity, and vitality. Improvements in 
fatigue were maintained for at least 6 months in both trials.
In summary, the current study is the first RCT of MBSR in cancer to use fatigue as the 
primary outcome, limit eligibility to adults with clinically significant levels of fatigue, and 
compare MBSR to controls at 1-month follow-up. Lack of an eligibility criterion related to 
heightened fatigue has been problematic in previous CRF studies, reducing the likelihood of 
detecting intervention effects and being inconsistent with how interventions are delivered in 
clinical practice [36]. Moreover, although there is no gold standard measure of CRF , a 
recent psychometric analysis of 18 CRF questionnaires recommended the Fatigue Symptom 
Inventory (FSI) as one of only three “excellent” measures [37]. No previously published 
MBSR study in cancer has included any of the “excellent” measures; however, the FSI was 
the measure used in the present trial.
Clinical Implications
Present findings substantially strengthen evidence supporting MBSR as a treatment for CRF. 
In 2014, the National Comprehensive Cancer Network (NCCN) added MBSR as an 
evidence-based intervention for fatigued post-treatment cancer survivors [2]. MBSR is listed 
as having “category 1” evidence, indicating NCCN consensus that the intervention is 
appropriate for use based on high-level evidence. However, the evidence cited was based on 
several quasi-experimental studies coupled with two RCTs comparing MBSR to wait-list 
control [20, 38]. Thus, the present study not only strengthens the evidence for MBSR as an 
efficacious intervention for CRF but adds new evidence that the beneficial effects are 
maintained at least up to 6 months. Positive findings related to feasibility and adherence in 
the present study may have particularly salient clinical implications, helping to answer 
questions about whether fatigued cancer survivors are willing and able to participate in a 
weekly meditation and yoga class that includes daily home practice.
Limitations
Study limitations include a small sample that yielded limited statistical power. In spite of 
this, 77.8% and 100% of the outcomes assessed at T2 and T3, respectively, were statistically 
significant, even after using a conservative Bonferroni correction for multiple comparisons. 
The sample was also from a single institution and not representative of the general 
population of people with cancer: most were women, the majority was white and college-
educated, and the majority had breast cancer. The heterogeneity in type and stage of cancer 
and anti-neoplastic treatments received in this sample precludes precise estimates of 
treatment effect in specific groups; however, it increases the generalizability of findings to 
real-world practice.
The potential for selection bias exists because the study included only patients who were 
willing to enroll in a clinical trial; therefore, bias could arise from unmeasured differences 
between patients who declined participation compared to those who agreed to participate. 
Even with such limits to generalizability, the influence of these biases on internal validity of 
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the study was minimized by random assignment to groups. Furthermore, as demonstrated in 
Table 1, randomization resulted in comparable groups with respect to potentially 
confounding variables, except for the three variables adjusted for in subsequent analyses.
Lack of an active comparison treatment or attention control is an important limitation, 
although use of a wait-list control condition was considered appropriate for this initial pilot 
study. Also, blinding to group assignment was not feasible, as is often the case in behavioral 
interventions—especially those using a wait-list control design.
Future Directions
Although the results of the present trial are not definitive, documenting feasibility, 
acceptability, and preliminary efficacy is an important step before proceeding to a larger 
RCT for efficacy. Before conclusive statements of efficacy are possible, adequately powered 
RCTs comparing MBSR to attention control are needed to account for time, attention, and 
outcome expectancies. Ideally, an attention control condition would utilize a group format 
and be structurally equivalent to MBSR in number and duration of sessions and amount of 
home practice. For the attention control intervention to have face value, minimize drop out, 
and address ethical concerns that might arise if an inert attention condition is offered, it may 
be useful to focus on topics relevant to cancer survivorship including surveillance and 
prevention of new or recurrent cancers, nutrition and weight management, and facts related 
to symptoms common in cancer survivors (e.g., sleep disturbance, depression, anxiety, pain, 
cognitive impairment, fatigue). Effectiveness trials comparing MBSR to exercise or 
cognitive behavioral therapy are also needed. Examination of the pre-post intervention 
change in various biomarkers in behavioral trials for CRF could shed light on our 
understanding of CRF and how integrative interventions such as MBSR may effectively 
address this complex symptom. One hypothesized pathway through which mindfulness-
based interventions may work is through reductions in pro-inflammatory cytokines, which 
have been linked to the onset and persistence of fatigue in cancer survivors [39]. 
Mindfulness has been shown to reduce inflammatory markers in cancer populations [40].
Conclusion
In undertaking this pilot study, we were responding to suggestions in extant literature that 
MBSR may be an intervention that is particularly well suited to help with clinically 
significant CRF. Study hypotheses were well supported—suggesting that MBSR may be 
both efficacious and acceptable—thereby providing compelling impetus to test this 
intervention in RCTs with larger samples of cancer patients suffering from persistent fatigue 
during and after treatment.
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Figure 1. 
CONSORT Diagram
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Figure 2. 
Figure 2(a) represents the randomized portion of the trial, comparing MBSR to wait-list 
control at two time points adjusted for baseline differences. Figure 2(b) represents the non-
randomized portion of the trial in which the wait-list controls received the MBSR training at 
the end of the 1-month follow-up. MBSR 1 represents the intervention group, and MBSR 2 
represents the wait-list control group. Each group's FSI fatigue interference score 
immediately before they began the MBSR course represents their baseline score, and the 
baseline score for each group is compared to their respective post-MBSR and 6-month 
follow-up scores.
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Table 1
Baseline Characteristics by Intervention Arm
Baseline Characteristics MBSR n = 18 Wait-List Control n = 17 p
Age, mean (SD) 58.8 (9.3) 55.7 (9.3) .33
Female, n (%) 17 (94) 16 (94) 1.00
White, n (%) 15 (83) 13 (76) .69
College education, n (%) 12 (67) 13 (77) .71
Married, n (%) 11 (61) 10 (59) .89
Employed, n (%) 9 (50) 8 (47) .86
Comfortable income, n (%) 9 (50) 12 (71) .21
Recent mental health treatment, n (%) 1 (5) 7 (41)
.01*
Symptom measures, mean (SD)
    FSI-Interference 4.35 (2.18) 4.46 (2.02) .88
    FSI-Severity 5.57 (1.58) 4.78 (1.30) .12
    SF-36 Vitality 36.6 (18.9) 29.3 (17.1) .24
    PHQ-8 Depression 7.89 (5.41) 8.94 (5.17) .56
    GAD-7 Anxiety 5.83 (4.57) 8.06 (4.90) .17
    ISI Sleep Disturbance 11.17 (6.67) 13.29 (7.05) .37
Five Facet Mindfulness Questionnaire
    Observing 28.11 (5.29) 24.35 (5.28)
.049*
    Describing 29.94 (5.87) 27.06 (7.91) .24
    Acting with Awareness 26.78 (6.32) 22.00 (8.66) .07
    Non-judging of inner experience 31.61 (6.09) 28.35 (7.75) .18
    Non-reactivity of inner experience 23.78 (3.57) 20.65 (3.72)
.02*
Type of cancer, n (%) .68
    Breast 15 (83.3) 15 (88.2)
    Esophageal 1 (5.56) 0 (0)
    Hematologic malignancies 2 (11.11) 2 (11.76)
Type of cancer treatment, n (%)
    Chemotherapy 11 (31) 12 (34) .56
    Radiation therapy 10 (29) 12 (34) .36
    Chemotherapy + Radiation 7 (20) 8 (23) .63
    Endocrine therapy 12 (34) 8 (23) .24
Cancer stage, n .20
    I 5 7
    II 5 7
    III 4 2
    IV 2 1
Note.
*Groups differed significantly at p < .05 on these variables. Each variable with significant differences was controlled for in subsequent analyses.
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Table 2
Efficacy of MBSR at Time 2 and Time 3
Time 2 Outcomes Adjusted Means
Dependent Variables MBSR (N=18) Control (N=17) Diff SE diff p* Pooled SD Effect Size 95% CI Effect Size
FSI Interference 2.11 4.58 −2.47 0.47 <0.001 1.73 −1.43 −1.96, −0.90
FSI Severity 3.03 5.57 −2.54 0.45 <0.001 1.64 −1.55 −2.09, −1.01
FSI Fatigue Days (0-7 
scale)
3.36 5.56 −2.20 0.53 <0.001 2.03 −1.08 −1.60, −0.57
FSI Percent of Day 
Fatigued
2.34 5.65 −3.31 0.53 <0.001 1.81 −1.83 −2.41, −1.25
SF-36 Vitality 52.96 33.22 19.75 4.54 <0.001 15.35 1.29 0.71, 1.87
Sheehan Disability Scale 2.60 3.49 −1.12 0.66 0.25 2.51 −0.45 −0.96, 0.07
PHQ-8 Depression 4.58 10.03 −5.46 1.10 <0.001 4.18 −1.30 −1.82, −0.79
GAD-7 Anxiety 3.91 5.92 −2.00 1.20 0.104 4.24 −0.47 −1.02, 0.08
ISI Sleep Disturbance 7.72 12.76 −5.04 1.41 0.001 6.81 −0.74 −1.15, −0.33
Time 3 Outcomes Adjusted Means
Dependent Variables MBSR (N=18) Control (N=17) Diff SE diff P* Pooled SD Effect Size 95% CI Effect Size
FSI Interference 1.88 4.59 −2.70 0.55 <0.001 2.01 −1.34 −1.88, −0.81
FSI Severity 3.22 5.54 −2.32 0.44 <0.001 1.51 −1.54 −2.10, −0.97
FSI Fatigue Days (0-7 
scale)
3.62 6.05 −2.44 0.57 <0.001 2.00 −1.22 −1.77, −0.66
FSI Percent of Day 
Fatigued
2.48 5.79 −3.31 0.63 <0.001 1.92 −1.73 −2.37, −1.08
SF-36 Vitality 56.49 30.42 26.08 4.76 <0.001 15.09 1.73 1.11, 2.35
Sheehan Disability Scale 2.09 4.69 −2.60 0.62 <0.002 2.13 −1.22 −1.79, −0.65
PHQ-8 Depression 3.59 11.91 −8.32 1.26 <0.001 4.86 −1.71 −2.22, −1.20
GAD-7 Anxiety 3.39 7.82 −4.43 1.29 0.002 4.54 −0.98 −1.53, −0.42
ISI Sleep Disturbance 6.57 13.36 −6.78 1.74 <0.001 6.76 −1.00 −1.51, −0.50
Note. Results are based on ANCOVA models comparing MBSR and controls at T2, and separately at T3, adjusting for T1 measure of the outcome 
variables, baseline mental health treatment, and the observing and describing subscales of the Five Facet Mindfulness Questionnaire. All Fatigue 
Symptom Inventory (FSI) subscales are rated on 0-10 scales except where indicated. The effect size for the SF-36 Vitality scale is in the opposite 
direction than the FSI effect sizes because the SF-36 Vitality scale is scored such that a higher score represents better vitality.
*Using Bonferroni correction for multiple comparisons, only p-values < 0.00278 (=.05/18) are considered significant.
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